Skip to main content
Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · IEX Real-Time Price · USD
1.720
+0.140 (8.86%)
At close: Jul 26, 2024, 4:00 PM
1.680
-0.040 (-2.33%)
After-hours: Jul 26, 2024, 6:55 PM EDT

Coherus BioSciences Revenue

Coherus BioSciences had revenue of $77.06M in the quarter ending March 31, 2024, with 137.58% growth. This brings the company's revenue in the last twelve months to $301.87M, up 64.63% year-over-year. In the year 2023, Coherus BioSciences had annual revenue of $257.24M with 21.89% growth.

Revenue (ttm)
$301.87M
Revenue Growth
+64.63%
P/S Ratio
0.65
Revenue / Employee
$986,507
Employees
306
Market Cap
197.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023257.24M46.20M21.89%
Dec 31, 2022211.04M-115.51M-35.37%
Dec 31, 2021326.55M-149.27M-31.37%
Dec 31, 2020475.82M119.75M33.63%
Dec 31, 2019356.07M--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TruBridge 336.45M
Lifecore Biomedical 103.27M
EDAP TMS 65.80M
Metagenomi 47.26M
Fennec Pharmaceuticals 44.95M
Alpha Teknova 36.85M
TriSalus Life Sciences 21.98M
MediWound 19.85M
Revenue Rankings

CHRS News

More News